O2256
Oxolamine citrate salt
Synonym(s):
5-(2-[Diethylamino]ethyl)-3-phenyl-1,2,4-oxadiazole citrate salt, NSC 100298
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C14H19N3O · C6H8O7
CAS Number:
Molecular Weight:
437.44
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
217-760-6
MDL number:
Quality Level
storage temp.
2-8°C
SMILES string
OC(=O)CC(O)(CC(O)=O)C(O)=O.CCN(CC)CCc1nc(no1)-c2ccccc2
InChI
1S/C14H19N3O.C6H8O7/c1-3-17(4-2)11-10-13-15-14(16-18-13)12-8-6-5-7-9-12;7-3(8)1-6(13,5(11)12)2-4(9)10/h5-9H,3-4,10-11H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)
InChI key
RBZIGQJSMCOHSS-UHFFFAOYSA-N
Application
Molecule involved in pharmacological studies including:
- Antiinflammatory agents
- Drugs that shift energy metabolism from mitochondrial respiration to glycolysis
- Effect on warfarin anticoagulant properties
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
J McEwen et al.
The Medical journal of Australia, 150(8), 449-450 (1989-04-17)
Twenty reports in Australia, Belgium and The Netherlands have implicated oxolamine-citrate cough-mixtures as a cause of hallucinations in children of less than 10 years of age. Fever is not thought to be a likely alternative explanation. Similar reactions in older
Effect of oxolamine on cough sensitivity in COPD patients.
B B Ceyhan et al.
Respiratory medicine, 96(1), 61-63 (2002-02-28)
Xuan Zhu et al.
Biopharmaceutics & drug disposition, 28(3), 125-133 (2007-02-14)
The possible reason for the significantly greater AUC of oral warfarin with oral oxolamine in male Sprague-Dawley rats was evaluated. After oral administration of warfarin at a dose of 2 mg/kg to male rats with oxolamine at doses of 10
Global Trade Item Number
| SKU | GTIN |
|---|---|
| O2256-25G | 04061834217886 |